Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine in ECT for Depression
NCT04399070Unknown
- Start
- Aug 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine in major depressive disorder (MDD) (3 arms). Primary endpoints: Hamilton Depression Scale-17 and Montgomery-Asberg Depression Rating Scale. Status: unknown.
02
Drugs
esketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04399070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04399070.